CAN is proud to welcome our new President-Elect, Freda Miller, who will take office in May 2014, and the newly elected Board members, Melanie Woodin, Edward Ruthazer, William Colmers and Charles Bourque! Read more in a special edition of the :
November 2013 CAN Connection
Interested in more news? You can read the September 2013 edition also
Air France's commitment to supporting biomedical research is to be commended. Their continued commitment to transporting live animals used for research is very important to neuroscientists.
We invite all our members and neuroscientists everywhere to write to Air France to thank them for this important support. Read more here
The Canadian Association for Neuroscience is proud to announce Dr. Shayna Rosenbaum, from York University, is the CAN 2013 Young Investigator Awardee.
Read Dr. Shayna Rosenbaum's profile and find representative publications on the 2013 Award page.
Have you listened to the "Think about it: A user's guide to the brain" radio series this Summer on the CBC? All shows are still available: Think about it website
Read "A Big Brainstorm is underway in Neuroscience", by Ivan Semeniuk, in the Globe and Mail (includes interviews with CAN members David Kaplan, Tim Murphy and Yves De Koninck).
Also on the CBC, Henry Friensen Prize winner Marc Tessier
Lavigne was interviewed by Paul Kennedy, host of Ideas.
Listen to Building Brains.
Visit our new Funding Opportunities webpage.
The page currently features new funding opportunities from :
Brain Canada - Platform Support Grants
The W. Garfield Weston Foundation 2013 Rapid Response:
Neurodegenerative Diseases of Aging grant program,
International Foundation for Research in Paraplegia.
Sam David, President of the Canadian Association for Neuroscience, has given a feature interview for the magazine International Innovation.
"International Innovation is the leading global dissemination resource for the wider scientific, technology and research communities, dedicated to disseminating the latest science, research and technological innovations on a global level. More information and a complimentary subscription offer to the publication can be found here"
A new University of British Columbia study identifies an important molecular change that occurs in the brain when we learn and remember.
Published this month in Nature Neuroscience, the research shows that learning stimulates our brain cells in a manner that causes a small fatty acid to attach to delta-catenin, a protein in the brain. This biochemical modification is essential in producing the changes in brain cell connectivity associated with learning, the study finds. +++ »
A new technique that targets proteins that cause disease and destroys “bad apples” in the cell has been developed by researchers at the University of British Columbia’s Brain Research Centre, part of Vancouver Coastal Health Research Institute.
The findings, published this month in Nature Neuroscience, has important implications for a variety of diseases, including Alzheimer’s, Huntington’s, stroke and even cancers, the researchers say. +++ »
A study led by University of British Columbia and Vancouver Coastal Health Research Institute researchers has revealed how the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is transmitted from cell to cell, and suggests the spread of the disease could be blocked.
“This work identifies an important piece of the puzzle in determining how the disease is transmitted throughout the nervous system,” says lead investigator Dr. Neil Cashman, UBC’s Canada Research Chair in Neurodegeneration and Protein Misfolding. “By understanding how this occurs, we can devise the best ways to stop the progressive neurological damage seen in ALS.” +++ »
There are usually three main tools for fighting brain cancer: surgery, radiation and chemotherapy. But for patients with ependymoma, a type of childhood brain tumour most common in babies, despite many clinical trials none of the standard chemotherapy medicines have been shown to help. While treatments for many other childhood cancers have changed and improved over the past two decades, chemotherapy for ependymoma has remained stagnant. The underlying cause of the chemo-resistance has baffled doctors until now. +++ »
More detailed scans could lead to better diagnosis and treatments
Multiple sclerosis (MS) is an unpredictable and debilitating neurodegenerative disease that affects an estimated 100,000 Canadians. Typically, Magnetic Resonance Imaging (MRI) is used to confirm diagnosis, but current techniques are limited in their ability to detect subtle differences in tissue damage. +++ »
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington’s disease (HD) and Parkinson’s disease. Stephen Ferguson, PhD, a scientist at Western’s Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviours in a HD mouse model when one of the major receptors in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted. The research is published online in Human Molecular Genetics. +++ »